bioAffinity Technologies: Accelerating the Future of Lung Cancer Detection with CyPath® Lung. bioAffinity Technologies, a leading player in the field of early cancer detection, recently reported an acceleration in sales growth of its revolutionary product, CyPath® Lung. This surge signifies a growing demand for innovative, non-invasive methods for early lung cancer detection and highlights the potential of CyPath® Lung to revolutionize the i...
bioAffinity Technologies股票討論區
Medical Technology Company Reports Major Revenue Growth
bioAffinity Technologies, a leading player in the field of early cancer detection, recently reported an acceleration in sales growth of its revolutionary product, CyPath® Lung. This surge signifies a growing demand for innovative, non-invasive methods for early lung cancer detection and highlights the potential of CyPath® Lung to revolutionize the i...
Slowly creeping up... keep it up!!
來啦,繼續瘋狂
堅定持有到年底20美元
it is about to turn green? 🤔
這個股票我會長揸,如果跌下來就加倉,我相信對於肺癌的早期確診對於醫療市場巨大利潤空間,年底股價會達到20美元。
wait and see what the move after open
暫無評論